Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NID2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | RBM34 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | SYNPO2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | RRAD | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | SAFB2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PALD1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PSMG2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ANXA7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | KPTN | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | BCL11A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |